Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
Celularity Inc. (CELU), a Delaware corporation, filed this Current Report on Form 8-K on July 21, 2025. The filing reports the entry into a material definitive agreement involving debt financing and the issuance of equity warrants.
Key Financial Metrics and Transaction Details
The Company issued a promissory note with the following terms:
- Principal Amount: $6,812,230
- Interest Rate: 2% per annum
- Maturity Date: March 21, 2026
- Security: Secured by a security interest on all of the Company's assets
Additionally, the investor received a warrant to purchase 3,700,000 shares of Class A common stock:
- Exercise Price: $2.528 per share
- Term: 5 years from issuance (subject to CFIUS clearance timing)
The filing does not provide specific revenue, profit, cash flow, or margin data for the period. The filing text does not provide a clear value for total debt or liquidity positions outside of this specific transaction.
Material Changes and Use of Proceeds
A material change in the Company's capital structure occurred through the new debt obligation. The Company has agreed that a portion of the net proceeds from this Note will be used to fully settle the principal and all accrued interest of a prior loan from C.V. Starr & Co. ("Starr") dated March 17, 2023.
Outlook, Risks, and Contingencies
Risks and Contingencies:
- Asset Security: The new Note is secured by all of the Company's assets, which may limit future borrowing capacity or operational flexibility.
- Regulatory Clearance: The warrant exercise period may be extended if the Committee on Foreign Investment in the United States (CFIUS) clearance is required.
- Dilution: The issuance of warrants for 3.7 million shares represents potential future dilution to existing shareholders.
The filing contains no forward-looking guidance regarding revenue or earnings.
Key Facts for Investor Verification
- Verify the exact amount of the outstanding Starr loan being settled to determine the net cash inflow from this transaction.
- Confirm the total outstanding debt load post-settlement to assess leverage ratios.
- Review the full text of the Promissory Note (Exhibit 10.1) for prepayment penalties or default triggers.
- Monitor the status of any required CFIUS clearance regarding the warrant exercise.